FOSRENOL TABLET (CHEWABLE) Canada - English - Health Canada

fosrenol tablet (chewable)

takeda canada inc - lanthanum (lanthanum carbonate hydrate) - tablet (chewable) - 750mg - lanthanum (lanthanum carbonate hydrate) 750mg - phosphate-removing agents

FOSRENOL TABLET (CHEWABLE) Canada - English - Health Canada

fosrenol tablet (chewable)

takeda canada inc - lanthanum (lanthanum carbonate hydrate) - tablet (chewable) - 1000mg - lanthanum (lanthanum carbonate hydrate) 1000mg - phosphate-removing agents

PMS-ISMN TABLET (EXTENDED-RELEASE) Canada - English - Health Canada

pms-ismn tablet (extended-release)

pharmascience inc - isosorbide-5-mononitrate - tablet (extended-release) - 60mg - isosorbide-5-mononitrate 60mg - nitrates and nitrites

PHL-ISMN TABLET (EXTENDED-RELEASE) Canada - English - Health Canada

phl-ismn tablet (extended-release)

pharmel inc - isosorbide-5-mononitrate - tablet (extended-release) - 60mg - isosorbide-5-mononitrate 60mg - nitrates and nitrites

DOM-ISMN TABLET (EXTENDED-RELEASE) Canada - English - Health Canada

dom-ismn tablet (extended-release)

dominion pharmacal - isosorbide-5-mononitrate - tablet (extended-release) - 60mg - isosorbide-5-mononitrate 60mg - nitrates and nitrites

PRO-ISMN - 60 TABLET (EXTENDED-RELEASE) Canada - English - Health Canada

pro-ismn - 60 tablet (extended-release)

pro doc limitee - isosorbide-5-mononitrate - tablet (extended-release) - 60mg - isosorbide-5-mononitrate 60mg - nitrates and nitrites

ISMN TABLET (EXTENDED-RELEASE) Canada - English - Health Canada

ismn tablet (extended-release)

sivem pharmaceuticals ulc - isosorbide-5-mononitrate - tablet (extended-release) - 60mg - isosorbide-5-mononitrate 60mg - nitrates and nitrites

DOXYCYCLINE HYCLATE tablet, film coated United States - English - NLM (National Library of Medicine)

doxycycline hyclate tablet, film coated

mayne pharma commercial llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 75 mg - doxycycline hyclate tablets are indicated for treatment of rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsial pox, and tick fevers caused by rickettsiae . doxycycline hyclate tablets are indicated for treatment of the following sexually transmitted infections: - uncomplicated urethral, endocervical or rectal infections caused by chlamydia trachomatis . - nongonococcal urethritis caused by ureaplasma urealyticum . - lymphogranuloma venereum caused by chlamydia trachomatis . - granuloma inguinale caused by klebsiella granulomatis . - uncomplicated gonorrhea caused by neisseria gonorrhoeae . - chancroid caused by haemophilus ducreyi . doxycycline hyclate tablets are indicated for treatment of the following respiratory tract infections: - respiratory tract infections caused by mycoplasma pneumoniae . - psittacosis (ornithosis) caused by chlamydophila psittaci . - because many strains of the following groups of microorganisms ha

DOXYCYCLINE HYCLATE tablet, film coated United States - English - NLM (National Library of Medicine)

doxycycline hyclate tablet, film coated

actavis pharma, inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 75 mg - doxycycline hyclate tablets are indicated for treatment of rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsial pox, and tick fevers caused by rickettsiae . doxycycline hyclate tablets are indicated for treatment of the following sexually transmitted infections: - uncomplicated urethral, endocervical or rectal infections caused by chlamydia trachomatis . uncomplicated urethral, endocervical or rectal infections caused by chlamydia trachomatis . - nongonococcal urethritis caused by ureaplasma urealyticum . nongonococcal urethritis caused by ureaplasma urealyticum . - lymphogranuloma venereum caused by chlamydia trachomatis . lymphogranuloma venereum caused by chlamydia trachomatis . - granuloma inguinale caused by klebsiella granulomatis . granuloma inguinale caused by klebsiella granulomatis . - uncomplicated gonorrhea caused by neisseria gonorrhoeae . uncomplicated gonorrhea caused by neisseria gonorrhoeae . - chancroid caused by haemophilus ducreyi . chancroid ca

DOXYCYCLINE HYCLATE tablet, delayed release United States - English - NLM (National Library of Medicine)

doxycycline hyclate tablet, delayed release

mylan pharmaceuticals inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 75 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate delayed-release tablets and other antibacterial drugs, doxycycline hyclate delayed-release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is a tetracycline-class antibacterial indicated in the following conditions or diseases: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae . uncomplicated urethral, endocervical or rectal infections caused by chlamydia trachomatis . nongonococcal urethritis caused by ureaplasma urealyticum . lymphogranuloma venereum caused by chlamydia t